An association study on contrasting cystic fibrosis endophenotypes recognizes KRT8 but not KRT18 as a modifier of cystic fibrosis disease severity and CFTR mediated residual chloride secretion

BMC Medical Genetics

Volumn 12, Issue , 2011, Pages

  Stanke, Frauke ^a   Hedtfeld, Silke ^a   Becker, Tim ^b   Tümmler, Burkhard ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORIDE ION; CYTOKERATIN; POTASSIUM ION; PROTEIN KRT18; PROTEIN KRT8; TRANSMEMBRANE CONDUCTANCE REGULATOR; UNCLASSIFIED DRUG; CFTR PROTEIN, HUMAN; CHLORIDE; CYTOKERATIN 18; CYTOKERATIN 8; KRT18 PROTEIN, HUMAN; KRT8 PROTEIN, HUMAN; MICROSATELLITE DNA;

ALLELE; ARTICLE; CELL DIFFERENTIATION; CHROMOSOME; COMPARATIVE STUDY; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE SEVERITY; ENDOPHENOTYPE; GENE; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; HAPLOTYPE; HUMAN; INTESTINE EPITHELIUM; ION CONDUCTANCE; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; TWINS; EPITHELIUM CELL; FEMALE; GENETICS; HOSPITALIZATION; MALE; METABOLISM;

CHLORIDES; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; ENDOPHENOTYPES; EPITHELIAL CELLS; FEMALE; HUMANS; KERATIN-18; KERATIN-8; MALE; MICROSATELLITE REPEATS; SEVERITY OF ILLNESS INDEX;

EID: 79955658463     PISSN: None     EISSN: 14712350     Source Type: Journal    
DOI: 10.1186/1471-2350-12-62     Document Type: Article

References (28)

1. Strausbaugh SD, Davis PB. Cystic fibrosis: a review of epidemiology and pathobiology. Clin Chest Med 2007, 28:279-288. 10.1016/j.ccm.2007.02.011, 17467547.
2. De Jonge HR, Ballmann M, Veeze H, Bronsveld I, Stanke F, Tümmler B, Sinaasappel M. Ex vivo CF diagnosis by intestinal current measurements (ICM) in small aperture, circulating Ussing chambers. J Cyst Fibros 2004, 3:159-163.
3. Schüler D, Sermet-Gaudelus I, Wilschanski M, Ballmann M, Dechaux M, Edelman A, Hug M, Leal T, Lebacq J, Lebecque P, Lenoir G, Stanke F, Wallemacq P, Tümmler B, Knowles MR. Basic protocol for transepithelial nasal potential difference measurements. J Cyst Fibros 2004, 3:151-155.
4. Collaco JM, Blackman SM, McGready J, Naughton KM, Cutting GR. Quantification of the relative contribution of environmental and genetic factors to variation in cystic fibrosis lung function. J Pediatr 2010, 157:802-807. 10.1016/j.jpeds.2010.05.018, 20580019.
5. Stanke F, Becker T, Kumar V, Hedtfeld S, Becker C, Cuppens H, Tamm S, Yarden J, Laabs U, Siebert B, Fernandez L, Macek M, Radojkovic D, Ballmann M, Greipel J, Cassiman JJ, Wienker TF, Tümmler B. Genes that determine immunology and inflammation modify the basic defect of impaired ion conductance in cystic fibrosis epithelia. J Med Genet 2011, 48:24-31. 10.1136/jmg.2010.080937, 3003880, 20837493.
6. Cutting GR. Modifier genetics: cystic fibrosis. Annu Rev Genomics Hum Genet 2005, 6:237-260. 10.1146/annurev.genom.6.080604.162254, 16124861.
7. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, Zou F, Zariwala M, Fargo D, Xu A, Dunn JM, Darrah RJ, Dorfman R, Sandford AJ, Corey M, Zielenski J, Durie P, Goddard K, Yankaskas JR, Wright FA, Knowles MR, . Gene Modifier Study Group Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 2005, 353:1443-1453. 10.1056/NEJMoa051469, 16207846, Gene Modifier Study Group.
8. Gu Y, Harley IT, Henderson LB, Aronow BJ, Vietor I, Huber LA, Harley JB, Kilpatrick JR, Langefeld CD, Williams AH, Jegga AG, Chen J, Wills-Karp M, Arshad SH, Ewart SL, Thio CL, Flick LM, Filippi MD, Grimes HL, Drumm ML, Cutting GR, Knowles MR, Karp CL. Identification of IFRD1 as a modifier gene for cystic fibrosis lung disease. Nature 2009, 458:1039-1042. 10.1038/nature07811, 2841516, 19242412.
9. Dorfman R, Li W, Sun L, Lin F, Wang Y, Sandford A, Paré PD, McKay K, Kayserova H, Piskackova T, Macek M, Czerska K, Sands D, Tiddens H, Margarit S, Repetto G, Sontag MK, Accurso FJ, Blackman S, Cutting GR, Tsui LC, Corey M, Durie P, Zielenski J, Strug LJ. Modifier gene study of meconium ileus in cystic fibrosis: statistical considerations and gene mapping results. Hum Genet 2009, 126:763-778. 10.1007/s00439-009-0724-8, 2888886, 19662435.
10. Welsh MJ, Smith AE. Molecular mechanisms of CFTR chloride channel dysfunction in cystic fibrosis. Cell 1993, 73:1251-1254. 10.1016/0092-8674(93)90353-R, 7686820.
11. Bronsveld I, Mekus F, Bijman J, Ballmann M, Greipel J, Hundrieser J, Halley DJ, Laabs U, Busche R, De Jonge HR, Tümmler B, Veeze HJ. Residual chloride secretion in intestinal tissue of deltaF508 homozygous twins and siblings with cystic fibrosis. Gastroenterology 2000, 119:32-40. 10.1053/gast.2000.8524, 10889152.
12. Bronsveld I, Mekus F, Bijman J, Ballmann M, de Jonge HR, Laabs U, Halley DJ, Ellemunter H, Mastella G, Thomas S, Veeze HJ, Tümmler B. Chloride conductance and genetic background modulate the cystic fibrosis phenotype of Delta F508 homozygous twins and siblings. J Clin Invest 2001, 108:1705-1715. 200980, 11733566.
13. Kubesch P, Dörk T, Wulbrand U, Kälin N, Neumann T, Wulf B, Geerlings H, Weißbrodt H, von der Hardt H, Tümmler B. Genetic determinants of airways' colonization with Pseudomonas aeruginosa in cystic fibrosis. Lancet 1993, 341:189-193. 10.1016/0140-6736(93)90062-L, 7678316.
14. Green DM, McDougal KE, Blackman SM, Sosnay PR, Henderson LB, Naughton KM, Collaco JM, Cutting GR. Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients. Respir Res 2010, 11:140. 10.1186/1465-9921-11-140, 2964615, 20932301.
15. John B, Lewis KR. Chromosome variability and geographic distribution in insects. Science 1966, 152:711-721. 10.1126/science.152.3723.711, 17797432.
16. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 2003, 160:636-645. 10.1176/appi.ajp.160.4.636, 12668349.
17. Okiyoneda T, Lukacs GL. Cell surface dynamics of CFTR: the ins and outs. Biochim Biophys Acta 2007, 1773:476-479. 10.1016/j.bbamcr.2007.01.004, 17306384.
18. Li C, Naren AP. CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners. Integr Biol (Camb) 2010, 2:161-177.
19. Davezac N, Tondelier D, Lipecka J, Fanen P, Demaugre F, Debski J, Dadlez M, Schrattenholz A, Cahill MA, Edelman A. Global proteomic approach unmasks involvement of keratins 8 and 18 in the delivery of cystic fibrosis transmembrane conductance regulator (CFTR)/deltaF508-CFTR to the plasma membrane. Proteomics 2004, 4:3833-3844. 10.1002/pmic.200400850, 15529338.
20. van Barneveld A, Stanke F, Tamm S, Siebert B, Brandes G, Derichs N, Ballmann M, Junge S, Tümmler B. Functional analysis of F508del CFTR in native human colon. Biochim Biophys Acta 2010, 1802:1062-1069.
21. Mekus F, Ballmann M, Bronsveld I, Bijman J, Veeze H, Tümmler B. Categories of deltaF508 homozygous cystic fibrosis twin and sibling pairs with distinct phenotypic characteristics. Twin Res 2000, 3:277-293. 10.1375/136905200320565256, 11463149.
22. Mekus F, Laabs U, Veeze H, Tümmler B. Genes in the vicinity of CFTR modulate the cystic fibrosis phenotype in highly concordant or discordant F508del homozygous sib pairs. Hum Genet 2003, 112:1-11. 10.1007/s00439-002-0839-7, 12483292.
23. Herold C, Becker T. Genetic association analysis with FAMHAP: a major program update. Bioinformatics 2009, 25:134-136.
24. Knapp M, Becker T. Family-based association analysis with tightly linked markers. Hum Hered 2003, 56:2-9. 10.1159/000073727, 14614233.
25. Becker T, Knapp M. A powerful strategy to account for multiple testing in the context of haplotype analysis. Am J Hum Genet 2004, 75:561-570. 10.1086/424390, 1182044, 15290652.
26. Stanke F, Becker T, Cuppens H, Kumar V, Cassiman JJ, Jansen S, Radojkovic D, Siebert B, Yarden J, Ussery DW, Wienker TF, Tümmler B. The TNFalpha receptor TNFRSF1A and genes encoding the amiloride-sensitive sodium channel ENaC as modulators in cystic fibrosis. Hum Genet 2006, 119:331-343. 10.1007/s00439-006-0140-2, 16463024.
27. Stanke F, Becker T, Hedtfeld S, Tamm S, Wienker TF, Tümmler B. Hierarchical fine mapping of the cystic fibrosis modifier locus on 19q13 identifies an association with two elements near the genes CEACAM3 and CEACAM6. Hum Genet 2010, 127:383-394. 10.1007/s00439-009-0779-6, 20047061.
28. Casanova ML, Bravo A, Ramírez A, Morreale de Escobar G, Were F, Merlino G, Vidal M, Jorcano JL. Exocrine pancreatic disorders in transsgenic mice expressing human keratin 8. J Clin Invest 1999, 103:1587-1595. 10.1172/JCI5343, 408365, 10359568.